Stifel Financial Corp Decreases Stock Holdings in Inari Medical, Inc. (NASDAQ:NARI)

Stifel Financial Corp lowered its holdings in shares of Inari Medical, Inc. (NASDAQ:NARI) by 14.1% in the 4th quarter, Holdings Channel.com reports. The firm owned 11,386 shares of the company’s stock after selling 1,873 shares during the quarter. Stifel Financial Corp’s holdings in Inari Medical were worth $581,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Smartleaf Asset Management LLC raised its position in shares of Inari Medical by 128.1% during the 4th quarter. Smartleaf Asset Management LLC now owns 634 shares of the company’s stock valued at $33,000 after buying an additional 356 shares in the last quarter. R Squared Ltd purchased a new position in Inari Medical in the fourth quarter worth about $45,000. Quadrant Capital Group LLC increased its stake in Inari Medical by 12.3% during the fourth quarter. Quadrant Capital Group LLC now owns 1,301 shares of the company’s stock worth $66,000 after acquiring an additional 143 shares during the last quarter. KBC Group NV increased its stake in Inari Medical by 31.5% during the fourth quarter. KBC Group NV now owns 2,333 shares of the company’s stock worth $119,000 after acquiring an additional 559 shares during the last quarter. Finally, PNC Financial Services Group Inc. raised its position in Inari Medical by 5.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 2,550 shares of the company’s stock valued at $130,000 after purchasing an additional 128 shares during the period. 90.98% of the stock is owned by hedge funds and other institutional investors.

Inari Medical Price Performance

NASDAQ:NARI opened at $79.97 on Monday. The firm has a market capitalization of $4.68 billion, a price-to-earnings ratio of -59.24 and a beta of 1.02. The business has a 50 day simple moving average of $79.97 and a 200-day simple moving average of $69.69. Inari Medical, Inc. has a 1 year low of $39.76 and a 1 year high of $79.99.

Inari Medical Profile

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.